Bialaphos (BA) is a tripeptide antibiotic produced by Streptomyces hygroscopicus SF1293 that is being used as a commercially important herbicide (13) . This compound is unique among natural products in possessing a C-P-C bond ( Fig. 1) .
We have previously characterized most of the biosynthetic pathway that converts a three-carbon primary metabolic precursor (phosphoenolpyruvate [PEP] ) to BA. At least 13 steps were defined by experiments using "C-labeled precursors, blocked mutants, and metabolic inhibitors (15) . Synthesis of the most intriguing part of the BA structure, i.e., the C-P bonds, has remained unclear. Since the discovery of the first natural C-P compound, 2-aminoethylphosphonic acid, by Horiguchi and Kandatsu (8) , several reports describing the isolation of C-P-containing compounds from various organisms have appeared.
In previous reports, we defined the formation of one C-P bond as step 5 in the BA biosynthetic pathway (Fig. 1) . The mutant NP213 was defective in the conversion of phosphonoformic acid (PF) and PEP to phosphinopyruvic acid (PPA) (10) . From a physicochemical point of view, direct formation of PPA by condensation between PF and PEP seemed unlikely, and the existence of an unidentified intermediate was implied. To dissect this potentially complex conversion, we attempted to obtain mutations in alleles distinct from that represented by NP213, using a gene replacement technique developed by Anzai et al. (1, 4) . As a result, we isolated a mutant (NP71) whose cell extract could restore BA production to NP213. Here we describe the isolation of mutant NP71 and the purification of a C-P bond-forming enzyme, named carboxyphosphonoenolpyruvate (CPEP) phosphonomutase, from NP71. In addition, we describe the isolation of the substrate of the enzyme, CPEP, which is accumulated by NP213. CPEP phosphonomutase catalyzes the C-P bond formation by intramolecular rearrangement of the carboxyphosphono group of CPEP to give PPA. * Corresponding author.
MATERIALS AND METHODS
Bacterial strains and plasmids. S. hygroscopicus HP782 and NP213 were obtained from the Meiji Seika Kaisha Culture Collection. HP782 is a high producer of BA, and NP213 is a nonproducing mutant defective in step 5 obtained by conventional N-methyl -N' -nitro -N-nitrosoguanidine treatment (10) . Plasmid pIJ486 was obtained from the John Innes Culture Collection (17) . Plasmid pMSB113 was constructed by the insertion of a 3.0-kilobase BamHI fragment containing a portion of the step 5 gene (2) into the BglIl site of pIJ486.
DNA manipulation and transformation. Plasmid preparations from S. hygroscopicus SF1293 were carried out as described by Murakami et al. (12) . An in vitro-derived mutation was introduced into the BA biosynthetic gene cluster of S. hygroscopicus according to the protocol of Anzai et al. (1) . Restriction enzymes, T4 DNA ligase, S1 nuclease, and calf intestinal alkaline phosphatase were used according to the recommendations of the suppliers. Transformation and regeneration of S. hygroscopicus protoplasts were carried out by the method of Murakami et al. (12) .
Biotransformation. For mixed cultures, two nonproducing mutants were cultured together under conditions that favor BA production. They were inoculated simultaneously into 500-ml Erlenmeyer flasks containing 100 ml of BA production medium (7% glucose, 3 overnight with 1 ml of the washed mycelium of a converter; the amount of BA produced was then determined by biological assay.
Starved mycelium of NP213 was prepared as follows. Washed mycelium of NP213 grown in BA production medium as described above was suspended in 50 mM phosphate buffer at a ratio of 1 g (wet weight) of mycelium per 10 ml of buffer. The mycelial suspension (100 ml) was shaken at 27°C for 5 h in a 500-ml Erlenmeyer flask on a rotary shaker. The mycelium was harvested by centrifugation and resuspended in the same buffer at a ratio of 1 g (wet weight) per 2 ml of buffer.
Purification of CPEP phosphonomutase from NP71. During the purification of CPEP phosphonomutase, its activity was monitored by the following biotransformation assay. Reaction mixtures containing 1 ml of crude enzyme and 1 ml of washed mycelium of NP213 grown in the liquid production medium for 5 days were incubated at 27°C for 18 h with vigorous shaking, and then the amount of BA produced was determined by biological assay as described above. One unit of CPEP phosphonomutase was defined as the amount of the enzyme producing 1 ,umol of BA under these conditions.
All purification operations were carried out at 4°C. Protein concentration was determined by using a Bio-Rad protein assay reagent according to the protocol of the supplier. Cultures of NP71 were grown at 27°C for 5 days in 500-ml Erlenmeyer flasks containing 60 ml of the liquid production medium as described above. The mycelium collected by centrifugation was washed twice with cold buffer A (50 mM morpholinoethanesulfonic acid [MES]-NaOH buffer, pH 6.5). The mycelium was then suspended in buffer A at a ratio of 1 g (wet weight) of mycelium per 2 ml of buffer and disrupted by sonication for 10 min at 4°C with a 600-W ultrasonic disintegrator (2N-100; Toyo Rika Co.). Unbroken cells and cell debris were removed by centrifugation (15,000 x g, 20 min). Solid ammonium sulfate was added slowly with constant stirring to the supernatant (300 ml containing 1,324.8 mg of protein) prepared from NP71 mycelium to give a final concentration of 60% saturation. The solution was centrifuged at 20,000 x g for 15 min, and the pellet was discarded. Additional ammonium sulfate was added to the supernatant to obtain a final concentration of 80% saturation, and the new precipitate was collected by centrifugation as described above. The pellet was dissolved in 10 ml of phosphate buffer (10 mM, pH 6.5) and applied to a hydroxylapatite column (10 by 200 mm; Bio-Gel HT; Pharmacia) equilibrated with the same buffer. The column was washed with 150 ml of 10 mM and then eluted with a linear gradient of 500 ml each of 10 and 200 mM phosphate buffers. All of the active fractions obtained by this procedure were pooled, and solid ammonium sulfate was added to a final concentration of 80%o. The pellet connected by centrifugation was dissolved in 2.0 ml of 50 mM Tris hydrochloride buffer (pH 7.5) and desalted by passage through a Sephadex G-25 PD-10 (Pharmacia) column equilibrated with 50 mM Tris hydrochloride buffer (pH 7.5). The desalted sample was applied to a Mono Q HR5/5 column (Pharmacia) previously equilibrated with 50 mM Tris hydrochloride buffer (pH 7.5). Protein was eluted from the column at a flow rate of 0.8 ml/min with a linear gradient 21 ml) of NaCl (0 to 0.8 M) made in the same buffer, using a Pharmacia high-pressure liquid chromatography (HPLC) system equipped with a UV detector. UV absorption was monitored at 280 nm. The active fractions were collected (500 jig) and further purified by HPLC on an Inatosil 300-C8 reverse-phase column (4.6 by 100 mm; Gasukuro Chemical Co.) that had been equilibrated with 0.1% trifluoroacetic acid and programmed for a linear gradient of 0 to 80o acetonitrile at a flow rate of 0.5 ml/min. The purified material (100 pug) was lyophilized and sequenced by Edman degradation with an Applied Biosystems protein sequencer (model 470A).
SDS-PAGE. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) was carried out according to Laemmli (11) . Samples were denatured at 100°C for 2 min in the presence of 1% SDS and 10% 2-mercaptoethanol and then subjected to electrophoresis on a 12.5 or 10 to 20% gradient polyacrylamide gel. The gel was stained for protein with Coomassie brilliant blue R-250 or silver staining reagent (Ag-Stain; Daiichi Pure Chemicals Co., Ltd.). A Bio-Rad low-molecular-weight kit was used as size standards (lysozyme, 14,000; soybean trypsin inhibitor, 21,000; carbonic anhydrase, 31,000; ovalbumin, 45,000; bovine serum albumin, 66,000; phosphorylase b, 93,000).
Determination of molecular weight by gel filtration. The molecular weight of CPEP phosphonomutase was determined with a TSK gel PW3000 column (Toso Co.) that had been equilibrated in 10 mM phosphate buffer (pH 6.5) containing 0.1 M NaCl. CPEP phosphonomutase (100 jig) and marker proteins (50 ,ug) were applied to the column, and elution was done with the same buffer at a flow rate of 0.5 ml/min. A280 was continuously monitored. The standard proteins used were RNase, chymotrypsinogen A, ovalbumin, and albumin (molecular weights of 13,700, 25,000, 45,000, and 67,000, respectively).
Isolation of CPEP and determination of structure. CPEP was isolated from the fermentation broth of mutant NP213. During purification, the amount of CPEP was monitored as follows. Test samples (0.5 ml) under purification were incu- bated at 27°C overnight with purified CPEP phosphonomutase (0.5 ml; 1 U; Mono Q active fraction) and the suspension of starved NP213 mycelia (1 ml); the amount of BA produced was determined by using the biological assay.
NP213 was cultured at 27°C for 5 days in the liquid production medium. The broth filtrate (1.2 liters) was stirred with activated carbon (100 g) for 30 min. After removal of the carbon by centrifugation, the supernatant was applied to a column of Dowex 1 (Cl-form; 4.5 by 40 cm). The column was washed with 1 liter each of water and 0.35 M NaCl, and CPEP was then eluted with 0.5 M NaCl. Fractions containing CPEP were pooled, concentrated to 10 ml, and applied to a column of HP20 (5.0 by 30 cm). The column was developed with water, and CPEP-rich fractions were further chromatographed on a DEAE-Sephadex A-25 column (Cl-; 2.0 by 20.0 cm). After washing of the column with 100 ml of water and 0.25 M NaCl, CPEP was eluted with 0.4 M NaCl. The final purification step consisted of chromatography on Sephadex G-10 (2.0 by 85.0 cm). The column was developed with water, and 10 mg of CPEP sodium salt was obtained as an amorphous white powder.
Quantification of the reaction product of CPEP and CPEP phosphonomutase. Formation of the CPEP phosphonomutase reaction product was measured by incubating 1 U of the enzyme in a total volume of 1 ml containing 50 mM MESNaOH buffer (pH 6.5) and 5 mM CPEP. After incubation at 30°C, the reaction mixture was boiled in a water bath for 2 min to stop the reaction and centrifuged at 20,000 x g for 5 min to remove the protein. The supernatant was then analyzed by biotransformation using NP213 as the converter as described above. Properties of CPEP phosphonomutase were analyzed by this method.
TLC analysis of the product of the CPEP phosphonomutase reaction. To identify the reaction product of CPEP and CPEP phosphonomutase, the reaction product was converted to a 2,4-dinitrophenylhydrazone (DNP) derivative. A reaction mixture (0.1 ml) containing 50 mM MES buffer (pH 6.5), 2 mM MnCl2, 10 mM CPEP, and 0.1 U of CPEP phosphonomutase was incubated at 30°C for 1 h, and then 0.01 ml of a DNP solution (2%, in 1 N HCl) was added. After 20 min, the mixture was extracted with an equal volume of ethyl acetate, and the ethyl acetate layer was analyzed by silica gel thin-layer chromatography (TLC) developed with 1-butanol-acetic acid-water (4: 1: 1), using a mono DNP derivative of PPA as a standard (Rf value, 0.45). Spots were visualized by UV illumination of TLC plates.
NMR analysis of the product of CPEP phosphonomutase reaction. A reaction mixture (10 ml) prepared as described above was incubated at 30°C for 3 h, and the protein was removed by ultrafiltration through Mol cut II GC (Japan Millipore Ltd.). The filtrate was applied to a column of DEAE-Sephadex A-25 (Cl-; 2.5 by 10 cm). The column was developed with a linear gradient of 500 ml each of 0.1 and 0.7 M NaCl, and the eluates were collected in 5-ml fractions. Each fraction was analyzed by biotransformation using NP213 as a converter. Fractions containing the reaction product(s) of CPEP phosphonomutase, which could be transformed to BA by NP213, were pooled and concentrated in vacuo to a volume of 2 ml and applied to a Sephadex G-10 column (2.5 by 100 cm) equilibrated with water. The 3-ml fractions were analyzed by biotransformation as described above, and the active fractions were concentrated in vacuo to dryness and dissolved in D20. 'H and 31P nuclear magnetic resonance (NMR) spectra were measured on a JEOL GX 400 spectrometer.
RESULTS
Construction of mutant NP71. NP71 was obtained from a BA producer, HP782, by the gene replacement technique. Plasmid pMSB113 contains a 3.0-kilobase BamHI DNA fragment including the region that restored BA production to NP213. Plasmid pMSB113, which has unique SstI site (Fig. 2 NP213 could utilize PF, they both could convert PPA to BA. This result showed that although neither of these strains could carry out the complex conversion previously referred to as step 5, they had genetically distinct defects. To our surprise, the washed mycelium of NP213 growth in the liquid production medium could form BA upon incubation with a cell extract of NP71, and the same result was obtained even after the removal of low-molecular-weight compounds from the extracts. On the other hand, a starved mycelium of NP213 could not produce BA when the same extract was added, and the addition of PF showed no effect (Table 1) . These results could be reasonably interpreted by assuming that in addition to PF, NP213 secreted an unknown intermediate (X; later shown to be CPEP) and that the cell extract of NP71 contained an enzyme absent in NP213 which catalyzed the conversion of X to a biosynthetic intermediate available to NP213 (later shown to be PPA). Therefore, we attempted to purify from NP71 the protein (later shown to be CPEP phosphonomutase) that restored BA production to NP213.
Purification of CPEP phosphonomutase. Enzyme activity was assayed by biotransformation experiments using NP213 as a converter as described in Materials and Methods. This enzyme was stable at 4°C for 1 week, and no loss of the activity was observed at -20°C for 1 month in an 80% ammonium sulfate suspension. CPEP phosphonomutase was purified about 200-fold in four steps with an overall yield of 7.2% from the crude extract (Table 2) . SDS-PAGE and reverse-phase HPLC indicated that the active fraction of Mono Q fast protein liquid chromatography (FPLC) was a pure enzyme (Fig. 3) . Its subunit molecular weight was determined to be 32,000 by SDS-PAGE. The first 30 aminoterminal amino acids of the protein purified by reverse-phase HPLC were determined by protein microsequencing to be AVTLARTFRELMNAPEILVVPSAYDALSA.
Previously, Murakami et al. (12) cloned a DNA fragment that restored BA productivity to NP213, and Anzai et al. (2) determined the nucleotide sequence of a SphI-SstI fragment in this DNA fragment. The amino acid sequence was identical with that deduced from the established nucleotide sequence. Thus, CPEP phosphonomutase proved to be the product of the gene that restored BA production to NP213. high-producer strain (HP5-29). The band of 32,000, corresponding to CPEP phosphonomutase, was not found in the NP213 lane, whereas large amounts of CPEP phosphonomutase were present in HP5-29.
Isolation of CPEP, a substrate of CPEP phosphonomutase from NP213. Although both NP213 and NP71 accumulated PF, the conversion results described above showed that NP213 contained another intermediate that was a substrate for CPEP phosphonomutase. This compound could be converted to BA by starved mycelia in the presence of NP71 extracts (Table 1) or purified CPEP phosphonomutase (data not shown).
We used this conversion as the assay method to purify the intermediate. Before use, NP213 mycelia were starved to eliminate BA intermediates. Although these mycelia in the presence of an NP71 extract were unable to convert PF, they could convert PPA or a component of the NP213 broth to BA. We therefore concluded that this compound in the NP213 broth was a previously unidentified intermediate between PF and PPA in the BA biosynthetic pathway. This new metabolite, named CPEP, was isolated from 1.2 liters of the NP213 broth filtrate after five purification steps as described in Materials and Methods, i.e., absorption to active carbon, Dowex 1 (Cl-) column chromatography, HP20 column chromatography, DEAE-Sephadex (Cl-) column chromatography, and Sephadex G-10 column chromatography. CPEP was obtained as a white amorphous powder (10 mg), and its structure (Fig. 1 ) was established mainly by 'H NMR and 13C NMR spectral analysis based on comparison with PEP (5).
Identification of the CPEP phosphonomutase reaction product. At an early stage of these studies, CPEP phosphonomutase was assayed only by incubation of the enzyme with washed mycelia of NP213 grown under BA production conditions because neither substrate nor product had been identified. With purified CPEP in hand, it has become possible to investigate the reaction catalyzed by CPEP phosphonomutase. Incubation of CPEP with purified CPEP phosphonomutase in the reaction mixture (1 ml) containing 50 mM MES (pH 6.5), 10 mM CPEP, and 1 U of CPEP phosphonomutase formed a product that could be converted to BA by washed mycelium of NP213 grown in P2 medium. The time course of the CPEP phosphonomutase reaction (Fig. 5) indicated that there was a linear relationship between time and the rate of formation of the product for the first 1-h 34% conversion. We chose the incubation time of 30 min to analyze the properties of this enzyme.
Since the reaction product was expected to be a keto derivative, we attempted to trap the product as its DNP. A reaction mixture (0.1 ml) was prepared as described in Materials and Methods was incubated at 30°C for 1 h. After incubation, the reaction mixture was treated with DNP, followed by extraction with ethyl acetate. The DNP derivative of the reaction product was identical in Rf value (0.45) by silica gel TLC with an authentic DNP derivative of PPA. Although this analytical method was highly sensitive, the enzymatic reaction product might have been overlooked by this experimental method, since treatment of the reaction mixture with DNP under acidic conditions would have caused decarboxylation of the putative intermediate 2 to give compound 3 (Fig. 1) .
To identify the CPEP phosphonomutase product in the native form, the product was isolated by two purification Fig. 1 ; presumably, decarboxylation of compound 2 occurred spontaneously, although the possibility that the decarboxylation was also catalyzed by CPEP phosphonomutase cannot be excluded.
Properties of CPEP phosphonomutase. The final enzyme preparation showed one major band stained by silver staining reagent on SDS-PAGE with a molecular weight of 32,000 + 1,000 (Fig. 3B) . During gel filtration on TSK gel PW3000, a CPEP phosphonomutase (1 U) was incubated in a total volume of 1 ml containing 50 mM MES-NaOH buffer (pH 6.5) and 5 mM CPEP. After incubation at 30°C for 30 min, the reaction mixture was boiled in a water bath for 2 min to stop the reaction, and the amount of PPA produced was determined by biotransformation using NP213 as the converter (see text).
CPEP phosphonomutase was eluted between bovine serum albumin (67,000) and ovalbumin (45,000). These results suggested a homodimeric structure.
CPEP phosphonomutase was found to be stable between pH 5.5 and 8.0, with the highest activity at pH 6.5. This enzyme showed maximum activity at 35°C. The enzyme did not lose activity appreciably at -20°C for 1 month in an 80o ammonium sulfate suspension and at 4°C for 1 week in 50 mM MES buffer (pH 6.5) at a concentration of 1 mg/ml. The Km for CPEP was estimated to be 0.25 mM from a HansWoolf plot. The effects of metal ions on CPEP phosphonomutase showed that Mn2' and Mg2+ increased the activity (Table 3 ). The enzyme was inactive in the presence of EDTA, but the 83.3% inhibition of CPEP phosphonomutase by 0.1 mM EDTA was completely relieved by addition of 1 mM MnSO4 or MgSO4 (Table 3) . NaCl, KCl, and NH4(SO4)2 up to a concentration of 100 mM did not affect CPEP phosphonomutase activity.
DISCUSSION
During biosynthetic studies of BA, Hidaka et al. (6) proposed a pathway containing three different types of C-P bond formation steps, i.e., intramolecular rearrangement of PEP (step 1), formation of PPA from PF and PEP (step 5), and P methylation of N-acetyl demethylbialaphos (step 12).
Previous studies concerning the C-P bond formation mechanism in Tetrahymena pyriformis (3, 7, 14, 16, 18) and C-P compound-producing actinomycetes (9) indicated that the C-P bond of step 1 was formed by intramolecular rearrangement of PEP to Pnpy via the same reaction catalyzed by PEP phosphomutase. We also reported that some other C-P compound-producing actinomycetes showed PEP phosphomutase activity (6) . Thus, it is suggested that the PEP phosphomutase reaction is common to the biosynthesis of various C-P compounds. In contrast to PEP phosphomutase, the C-P bond formation in step 5 has been considered to be specific for BA biosynthesis.
In this study, we report for the first time the isolation from BA-nonproducing mutant NP71 of an enzyme catalyzing the C-P bond formation in step 5. In addition, we isolated the substrate of the enzyme from the broth filtrate of NP213; chemical analysis showed that it was a new C-P compound named CPEP. CPEP has a hybrid structure of PEP and PF, i.e., P-carboxylated PEP. The structure strongly suggests that CPEP is formed by transesterification between PF and PEP. This study is a rare case in which the enzyme was purified before isolation of the substrate. CPEP is extremely unstable and produced in only trace amounts by NP213. For these reasons, CPEP was not detected by the conventional cosynthesis or biotransformation methods. NP71 could transform CPEP to BA, although it could not utilize PF (data not shown). These results suggest that NP71 is defective in the formation of CPEP from PF and PEP (Fig. 1, 5a) , in contrast to NP213, which is defective in the CPEP phosphonomutase reaction (Fig. 1, Sb) .
The sequence of the first 30 N-terminal amino acids of CPEP phosphonomutase was completely identical with the sequence deduced from the nucleotide sequence of the gene that restored BA production to NP213. Thus, CPEP phosphonomutase turned out to be a step Sb gene product. We found that a cell extract of NP213 catalyzed the formation of CPEP from PEP and PF and that NP71 lacked this activity (unpublished data). These findings strongly suggest that the enzyme catalyzing the condensation between PEP and PF is encoded by the 5a region in the cluster containing the site of the NP71 mutation (Fig. 2) .
CPEP phosphonomutase was produced in large amounts by high-producer strain HP5-29. This result suggests that the CPEP phosphonomutase reaction represents one of the key rate-limiting steps of the BA biosynthetic pathway. Further studies of the properties and reaction mechanism of this enzyme may contribute to improvement of BA production by S. hygroscopicus.
